This message was posted by a user wishing to remain anonymous
This may depend on the OHT, but this was common in our field. I have done this multiple times and seen in the approval database that competitors also did so. As long as the risk of one doesn't have an effect on the other, you should be able to make a good argument that they can be reviewed independently and in parallel.
Original Message:
Sent: 10-Nov-2022 16:13
From: Anonymous Member
Subject: Parallel PMA Supplements
This message was posted by a user wishing to remain anonymous
Does anyone have any experience with FDA of submitting parallel (not serial) 180-Day PMA supplements - one for a manufacturing site transfer and the other for a device design change?